Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OXALIPLATIN vs OXAPROZIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OXALIPLATIN vs OXAPROZIN: Safety Overview

Metric OXALIPLATIN OXAPROZIN
Total FAERS Reports 56,406 439
Deaths Reported 6,501 4
Death Rate 11.5% 0.9%
Hospitalizations 21,980 23
Average Patient Age 61.5 yrs 62.9 yrs
% Female Patients 42.1% 83.8%
FDA Approval Date Apr 28, 2011 Apr 12, 2001
Manufacturer Camber Pharmaceuticals, Inc. Dr. Reddy's Laboratories Limited
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription